Cargando…
Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
Aluminium salts are by far the most commonly used adjuvants in vaccines. There are only two aluminium salts which are used in clinically-approved vaccines, Alhydrogel(®) and AdjuPhos(®), while the novel aluminium adjuvant used in Gardasil(®) is a sulphated version of the latter. We have investigated...
Autores principales: | Shardlow, Emma, Mold, Matthew, Exley, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223008/ https://www.ncbi.nlm.nih.gov/pubmed/30455719 http://dx.doi.org/10.1186/s13223-018-0305-2 |
Ejemplares similares
-
Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
por: Mold, Matthew, et al.
Publicado: (2016) -
From Stock Bottle to Vaccine: Elucidating the Particle Size Distributions of Aluminum Adjuvants Using Dynamic Light Scattering
por: Shardlow, Emma, et al.
Publicado: (2017) -
Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line
por: Mold, Matthew, et al.
Publicado: (2014) -
Imaging of aluminium and amyloid β in neurodegenerative disease
por: Exley, Christopher, et al.
Publicado: (2020) -
Aluminium co-localises with Biondi ring tangles in Parkinson’s disease and epilepsy
por: Mold, Matthew John, et al.
Publicado: (2022)